needed.
Special precautions for use
Special precautions for use in animals
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Avoid use in very severely dehydrated, hypovolaemic or hypotensive animals which require parenteral rehydration, as there may be a potential risk of renal toxicity.
In cases of inadequate relief of pain when used in the treatment of equine colic, careful re-evaluation of the diagnosis should be made as this could indicate the need for surgical intervention.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
Accidental self injection may cause pain. People with known hypersensitivity to Non-Steroidal Anti- Inflammatory Drugs (NSAIDs) should avoid contact with the veterinary medicinal product.
In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.
Adverse reactions (frequency and seriousness)
Administration of the veterinary medicinal product by the subcutaneous route in cattle and the intramuscular route in pigs is well tolerated; only a slight transient swelling at the injection site following subcutaneous administration was observed in cattle treated in clinical studies.
In horses, a transient swelling at the injection site can occur but resolved without intervention.
In very rare cases anaphylactoid reactions, which may be serious (including fatal), may occur and should be treated symptomatically.
The frequency of adverse reactions is defined using the following convention:
•very common (more than 1 in 10 animals treated displaying adverse reactions)
•common (more than 1 but less than 10 animals treated in 100 animals)
•uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
•rare (more than 1 but less than 10 animals in 10,000 animals treated)
•very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
Use during pregnancy, lactation or lay
Cattle and Pigs: Can be used during pregnancy and lactation.
Horses: Do not use in pregnant or lactating mares.
Interaction with other medicinal products and other forms of interaction
Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Our Standard Delivery - £6.75
Royal Mail Tracked 24 (Signed For)
- Next business day service
- Compensation cover up to £100
- Signature on delivery
Any orders placed after close of business on Thursday will not be delivered until Tuesday
Our Express Delivery - £10.45
Royal Mail Special Delivery Guaranteed by 1pm
- Next business day service
- Insured up to £500
- Signature on delivery
Please note that all chilled deliveries must be sent on an Express service.
Chilled orders placed after close of business on Wednesday will not be despatched until Monday
You must be logged in to write review
Category
|
POM-V
|
Temperature
|
Ambient
|
MA/VM/EU No:
|
02000/5005
|
Species
|
|
VMD Link
|
https://www.vmd.defra.gov.uk/ProductInformationDatabase/product/A007952
|
NOAH Link
|
|
Dosage
|
Amounts to be administered and administration route
Cattle:
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e., 2.5 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate. The recommended maximum volume to be administered at a single injection site is 10ml.
Pigs:
Single intramuscular injection at a dosage of 0.4 mg meloxicam/kg body weight (i.e., 2.0 ml/100 kg body weight) in combination with antibiotic therapy, as appropriate. If required, a second administration of meloxicam can be given after 24 hours. The recommended maximum volume to be administered at a single injection site is 2 ml.
Horses:
Single intravenous injection as a dosage of 0.6 mg meloxicam/kg body weight (i.e., 3.0 ml/100 kg body weight).
For use in the alleviation of inflammation and the relief of pain in both acute and chronic musculoskeletal disorders, a suitable oral therapy containing meloxicam, administered in accordance with label recommendations, may be used for continuation of treatment.
Avoid introduction of contamination during use.
Do not exceed 50 broachings per vial. If more than 50 broachings are required, the use of a draw-off needle is recommended.
Overdose (symptoms, emergency procedures, antidotes), if necessary
In the case of overdose, symptomatic treatment should be initiated.
|
Withdrawals
|
|